Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.
Joanna Klubo-GwiedzdzinskaMaria LangeElaine CochranRobert K SempleCornelia GewertRebecca J BrownPhillip GordenPublished in: Diabetes care (2018)
Combined immunosuppressive therapy has changed the natural history of this disease, from 54% mortality to a curable form of diabetes and, as such, should be recommended in patients with type B insulin resistance.
Keyphrases
- insulin resistance
- type diabetes
- adipose tissue
- metabolic syndrome
- high fat diet
- glycemic control
- polycystic ovary syndrome
- cardiovascular disease
- skeletal muscle
- cardiovascular events
- early onset
- stem cells
- risk factors
- systemic lupus erythematosus
- high fat diet induced
- rheumatoid arthritis
- bone marrow
- mesenchymal stem cells